Neurentis PLC
Registered name: NEURENTIS PLC
Neurentis PLC made £0 revenue and a £43.3k loss in the year to 30 Nov 2025. read from filing text
Neurentis PLC’s revenue was £0 in the year to 30 Nov 2025, with a loss of £43.3k and 3 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in London; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- London, London
- Age
- 3 yrs · since 2022
- Type
- Public Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Nov 2023 | 30 Nov 2024 | 30 Nov 2025 |
|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | |||
| Revenue (turnover) | £0 | £0 | £0 |
| Gross profit | £0 | £0 | £0 |
| Operating profit | −£27.1k | −£37.5k | −£43.3k |
| Profit before tax | −£27.1k | −£37.5k | −£43.3k |
| Profit after tax | −£27.1k | −£37.5k | −£43.3k |
| Profit (best available) | −£27.1k | −£37.5k | −£43.3k |
| Employees (average) | 3 | 3 | 3 |
| Ratios | |||
| Profit margin | — | — | — |
| Revenue per employee | £0 | £0 | £0 |
| Profit per employee | −£9k | −£12.5k | −£14.4k |
| Growth (year on year) | |||
| Headcount growth | — | 0% | 0% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £428 | £37.2k | £49.5k |
| Net assets | £2.1m | £2.1m | £2.1m |
| Current assets | £139k | £88k | £70.9k |
| Debtors | £138k | £50.8k | £21.4k |
| Cash from operations | −£11.5k | −£28.7k | −£17.7k |
| Source | FullAccounts · bulk data May 2025 | FullAccounts · bulk data May 2025 | FullAccounts · bulk data May 2026 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £0
- Revenue ÷ average employees.
- Profit per employee
- −£14.4k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼2%
- Now £2.1m
- Cash at bank
- ▲33%
- Now £49.5k
- Headcount
- 0%
- Now 3
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Subsidiaries (1)
- Neurentis(UK) LtdFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Porvair PLCKings Lynn · Manufacture of basic pharmaceutical products
- Revenue
- £194m
- Profit
- £18.2m
- Staff
- 1,011
- RSR LimitedLancaster · Manufacture of basic pharmaceutical products
- Revenue
- £22.2m
- Profit
- £17.7m
- Staff
- 96
- T.G. Eakin LimitedComber · Manufacture of basic pharmaceutical products
- Revenue
- £41.3m
- Profit
- £14m
- Staff
- 155
- Herrco Cosmetics LimitedHalesworth · Manufacture of basic pharmaceutical products
- Revenue
- £40.4m
- Profit
- £5.7m
- Staff
- 179
- Manx Healthcare LimitedWarwick · Manufacture of basic pharmaceutical products
- Revenue
- £12.6m
- Profit
- £5.6m
- Staff
- 31
- West Pharmaceutical Services Cornwall LimitedLondon · Manufacture of basic pharmaceutical products
- Revenue
- £51.3m
- Profit
- £3.6m
- Staff
- 206
Sources
Latest figures from FullAccounts for the year to 30 Nov 2025 (profit −£43.3k), from the Companies House accounts bulk data published May 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.